Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
385 | 29018 | 33.2 | 71% |
Classes in level above (level 4) |
Classes in level below (level 2) |
ID, lev. below |
Publications | Label for level below |
---|---|---|
1301 | 8126 | ANTIPHOSPHOLIPID SYNDROME//ANTIPHOSPHOLIPID ANTIBODIES//LUPUS ANTICOAGULANT |
1388 | 7661 | CONGENITAL HEART BLOCK//NEONATAL LUPUS//NEONATAL LUPUS ERYTHEMATOSUS |
1472 | 7159 | SYSTEMIC LUPUS ERYTHEMATOSUS//LUPUS//LUPUS NEPHRITIS |
1725 | 6072 | HYPEREMESIS GRAVIDARUM//MOTHERISK PROGRAM//NAUSEA AND VOMITING OF PREGNANCY |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ANTIPHOSPHOLIPID SYNDROME | Author keyword | 1822 | 71% | 5% | 1467 |
2 | SYSTEMIC LUPUS ERYTHEMATOSUS | Author keyword | 1709 | 39% | 12% | 3477 |
3 | ANTIPHOSPHOLIPID ANTIBODIES | Author keyword | 1508 | 74% | 4% | 1113 |
4 | LUPUS | Journal | 1317 | 52% | 6% | 1800 |
5 | LUPUS ANTICOAGULANT | Author keyword | 998 | 76% | 2% | 704 |
6 | ANTICARDIOLIPIN ANTIBODIES | Author keyword | 904 | 76% | 2% | 628 |
7 | BETA2 GLYCOPROTEIN I | Author keyword | 683 | 85% | 1% | 366 |
8 | LUPUS NEPHRITIS | Author keyword | 399 | 46% | 2% | 654 |
9 | SLE | Author keyword | 265 | 33% | 2% | 653 |
10 | CONGENITAL HEART BLOCK | Author keyword | 256 | 81% | 1% | 154 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ANTIPHOSPHOLIPID SYNDROME | 1822 | 71% | 5% | 1467 | Search ANTIPHOSPHOLIPID+SYNDROME | Search ANTIPHOSPHOLIPID+SYNDROME |
2 | SYSTEMIC LUPUS ERYTHEMATOSUS | 1709 | 39% | 12% | 3477 | Search SYSTEMIC+LUPUS+ERYTHEMATOSUS | Search SYSTEMIC+LUPUS+ERYTHEMATOSUS |
3 | ANTIPHOSPHOLIPID ANTIBODIES | 1508 | 74% | 4% | 1113 | Search ANTIPHOSPHOLIPID+ANTIBODIES | Search ANTIPHOSPHOLIPID+ANTIBODIES |
4 | LUPUS ANTICOAGULANT | 998 | 76% | 2% | 704 | Search LUPUS+ANTICOAGULANT | Search LUPUS+ANTICOAGULANT |
5 | ANTICARDIOLIPIN ANTIBODIES | 904 | 76% | 2% | 628 | Search ANTICARDIOLIPIN+ANTIBODIES | Search ANTICARDIOLIPIN+ANTIBODIES |
6 | BETA2 GLYCOPROTEIN I | 683 | 85% | 1% | 366 | Search BETA2+GLYCOPROTEIN+I | Search BETA2+GLYCOPROTEIN+I |
7 | LUPUS NEPHRITIS | 399 | 46% | 2% | 654 | Search LUPUS+NEPHRITIS | Search LUPUS+NEPHRITIS |
8 | SLE | 265 | 33% | 2% | 653 | Search SLE | Search SLE |
9 | CONGENITAL HEART BLOCK | 256 | 81% | 1% | 154 | Search CONGENITAL+HEART+BLOCK | Search CONGENITAL+HEART+BLOCK |
10 | LUPUS | 241 | 37% | 2% | 528 | Search LUPUS | Search LUPUS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ANTICARDIOLIPIN ANTIBODIES | 2820 | 70% | 8% | 2369 |
2 | BETA2 GLYCOPROTEIN I | 1607 | 80% | 3% | 987 |
3 | ERYTHEMATOSUS | 994 | 45% | 6% | 1675 |
4 | SYSTEMIC LUPUS ERYTHEMATOSUS | 894 | 19% | 15% | 4351 |
5 | ANTIPHOSPHOLIPID ANTIBODIES | 844 | 49% | 4% | 1263 |
6 | ANTI BETA2 GLYCOPROTEIN I ANTIBODIES | 605 | 92% | 1% | 240 |
7 | NEONATAL LUPUS | 518 | 86% | 1% | 260 |
8 | CONGENITAL HEART BLOCK | 430 | 73% | 1% | 332 |
9 | ANTICOAGULANT | 408 | 36% | 3% | 922 |
10 | RECOGNIZE BETA2 GLYCOPROTEIN I | 397 | 94% | 0% | 141 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LUPUS | 1317 | 52% | 6% | 1800 |
2 | AUTOIMMUNITY REVIEWS | 46 | 17% | 1% | 250 |
3 | JOURNAL OF AUTOIMMUNITY | 36 | 12% | 1% | 280 |
4 | RHEUMATIC DISEASE CLINICS OF NORTH AMERICA | 18 | 11% | 1% | 156 |
5 | CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY | 11 | 11% | 0% | 96 |
6 | CURRENT RHEUMATOLOGY REPORTS | 7 | 13% | 0% | 49 |
7 | ACTA REUMATOLOGICA PORTUGUESA | 5 | 11% | 0% | 45 |
8 | METHODS-A COMPANION TO METHODS IN ENZYMOLOGY | 1 | 11% | 0% | 8 |
9 | DIAGNOSTIC AND CLINICAL IMMUNOLOGY | 1 | 11% | 0% | 7 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) | 2006 | 1875 | 123 | 93% |
A volcanic explosion of autoantibodies in systemic lupus erythematosus: A diversity of 180 different antibodies found in SLE patients | 2015 | 5 | 41 | 83% |
Medical progress: The antiphospholipid syndrome. | 2002 | 772 | 78 | 95% |
International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies | 2014 | 38 | 43 | 79% |
Mechanisms of disease: Systemic lupus erythematosus | 2008 | 605 | 79 | 51% |
Brain abnormalities in newly diagnosed neuropsychiatric lupus: Systematic MRI approach and correlation with clinical and laboratory data in a large multicenter cohort | 2015 | 4 | 42 | 88% |
The Pathogenesis of the Antiphospholipid Syndrome | 2013 | 94 | 99 | 72% |
The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: Data from a European multicenter retrospective study | 2015 | 3 | 14 | 100% |
Patient-level analysis of five international cohorts further confirms the efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies | 2015 | 3 | 23 | 96% |
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis | 2012 | 102 | 162 | 73% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LUPUS UNIT | 202 | 63% | 0.7% | 204 |
2 | AUTOIMMUNE DIS | 103 | 33% | 0.9% | 262 |
3 | BARBARA VOLCKER WOMEN RHEUMAT DIS | 89 | 90% | 0.1% | 38 |
4 | LUPUS CLIN | 79 | 72% | 0.2% | 63 |
5 | MOTHERISK PROGRAM | 69 | 40% | 0.5% | 133 |
6 | ANTIPHOSPHOLIPID STANDARDIZAT | 65 | 95% | 0.1% | 21 |
7 | BLOOMSBURY RHEUMATOL UNIT | 46 | 63% | 0.2% | 46 |
8 | PROGNOSIS STUDIES RHEUMAT DIS | 44 | 38% | 0.3% | 93 |
9 | SECT TRAUMA BURNS CRIT CARE | 33 | 75% | 0.1% | 24 |
10 | ALLERGY CLIN IMMUNOL RHEUMATOL UNIT | 31 | 73% | 0.1% | 24 |
Related classes at same level (level 3) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000003124 | RHEUMATOID ARTHRITIS//RHEUMATOLOGY//RHEUMATOL |
2 | 0.0000003104 | BEHCETS DISEASE//WEGENERS GRANULOMATOSIS//GIANT CELL ARTERITIS |
3 | 0.0000003006 | COMPLEMENT//JOURNAL OF IMMUNOLOGY//COMMON VARIABLE IMMUNODEFICIENCY |
4 | 0.0000001752 | IGA NEPHROPATHY//RENAL ARTERY STENOSIS//NEPHROTIC SYNDROME |
5 | 0.0000001638 | LOW BACK PAIN//SYSTEMIC SCLEROSIS//SCLERODERMA |
6 | 0.0000001585 | PHAGE DISPLAY//CATALYTIC ANTIBODIES//CATALYTIC ANTIBODY |
7 | 0.0000001567 | TOXIC EPIDERMAL NECROLYSIS//STEVENS JOHNSON SYNDROME//DRUG HYPERSENSITIVITY |
8 | 0.0000001428 | OBSTETRICS & GYNECOLOGY//PRE ECLAMPSIA//AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY |
9 | 0.0000001422 | PRIMARY BILIARY CIRRHOSIS//AUTOIMMUNE HEPATITIS//PRIMARY SCLEROSING CHOLANGITIS |
10 | 0.0000001408 | MYASTHENIA GRAVIS//GUILLAIN BARRE SYNDROME//THYMOMA |